Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 9.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Headquarters
Avenida Adolfo Lopez Mateos 68, Col. Cuajimalpa
Mexico City; Federal District of Mexico City; Map
Postal Code: 05000
Tel: +52 555814
Website: http://www.liomont.com

Full name: Laboratorios Liomont S.A. de C.V.

Status: Non-Listed
Legal Form: Limited Liability Company
Operational Status: Operational
EMISid: 2343911
RFC: LLI811201IX6

Main Activities

Main Activities: Chemical Manufacturing

Main Products

Pharmaceutical

Company Description

Laboratorios Liomont, founded in 1938 is dedicated to the production and commercialization of prescription pharmaceuticals and OTC. It currently has a processing plant with annual production capacity of 120 million units. Since 1997 it has dabbled in the markets of Guatemala, El Salvador, Panama, Republic Dominicana, Venezuela, Colombia, Ecuador and Peru.

More

Basic Information

Total Employees:
()

Key Executives

Commercial Director

Competitors - Mexico

N | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 9.95 USD
Payment methods include:
USD 9.95
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest